Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
Rosato
Adriana E
AE
Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Tallent
Sandra M
SM
Edmond
Michael B
MB
Bearman
Gonzalo M L
GM
D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D016470:Bacteremia / Q000517:prevention & control; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation*; D002408:Catheters, Indwelling; D002710:Chlorhexidine / Q000494:pharmacology*; D003030:Coagulase / Q000032:analysis; D003428:Cross Infection / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D004867:Equipment Design; D006801:Humans; D012837:Silver Sulfadiazine / Q000494:pharmacology*; D013203:Staphylococcal Infections / Q000517:prevention & control; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology
D000891:Anti-Infective Agents, Local; D003030:Coagulase; D002710:Chlorhexidine; D012837:Silver Sulfadiazine